Keyphrases
Homologous Recombination Deficiency
100%
Clinical Assay
100%
DNA Repair
30%
Homologous Recombination
30%
Double-strand Breaks
30%
Fork Degradation
30%
Tumor
20%
High-grade Serous Ovarian Cancer (HGSOC)
20%
Functional Assay
20%
Replication Fork
20%
PARP Inhibitor (PARPi)
20%
RAD51 Foci
20%
Clinical Outcomes
10%
Somatic mutation
10%
DNA Damage
10%
Tumor Cells
10%
Focus Formation
10%
Chemotherapy
10%
Gene mutation
10%
Clinical Detection
10%
Cell Viability
10%
DNA Repair Genes
10%
Tumor Response
10%
Central Pathway
10%
Improved Survival
10%
DNA Synthesis
10%
Platinum-based Chemotherapy
10%
Non-homologous End Joining
10%
Genetic mutation
10%
Germline mutation
10%
Resume
10%
Genomic Instability
10%
Mutation Pattern
10%
Stall
10%
Platinum Sensitivity
10%
Chemosensitivity
10%
Alternate Pathway
10%
Replication Stress
10%
BRCA Deficiency
10%
Genomic Changes
10%
DNA Fiber Assay
10%
Replication Fork Stalling
10%
Genomic Scars
10%
Inhibitor Sensitivity
10%
PARP Inhibitor Sensitivity
10%
Error-prone Repair
10%
Medicine and Dentistry
Homologous Recombination
100%
DNA Repair
30%
Neoplasm
23%
PARP Inhibitor
23%
Ovarian Cancer
15%
DNA Damage
7%
Somatic Mutation
7%
Cancer
7%
Tumor Cell
7%
Genomic Instability
7%
Cell Viability
7%
Translating (Language)
7%
DNA Synthesis
7%
Germline Mutation
7%
Chemosensitivity
7%
Non-Homologous End Joining
7%
Biochemistry, Genetics and Molecular Biology
Homologous Recombination
100%
DNA Repair
30%
Poly ADP Ribose Polymerase
23%
Genomics
23%
RAD51
15%
DNA Damage
7%
Somatic Mutation
7%
Genome Instability
7%
Cell Viability
7%
Non-Homologous End Joining
7%
DNA Synthesis
7%
Translating (Language)
7%
Germline Mutation
7%
Chemosensitivity
7%
Immunology and Microbiology
Homologous Recombination
100%
DNA Repair
30%
Tumor Cell
7%
Genomic Instability
7%
DNA Synthesis
7%
DNA Damage
7%
Cell Viability
7%
Germline Mutation
7%
Chemosensitivity
7%
DNA End Joining Repair
7%
Somatic Mutation
7%